Market Place
Sourcing Support
Chung-Ang Researchers Reveal Transfer RNA`s Role In Cancer Progress
12 Dec 2024 //
PR NEWSWIRE
n-Lorem Hosts Nano-Rare Colloquium With 750+ Attendees
12 Dec 2024 //
BUSINESSWIRE
Private Medicare Plans Must Cover Biogen`s ALS Drug
12 Dec 2024 //
REUTERS
Leqembi (Lecanemab) Launched in South Korea for Alzheimer`s Disease
27 Nov 2024 //
PR NEWSWIRE
Dapirolizumab Pegol Ph 3 Data Shows Lupus Disease Activity Reduction
19 Nov 2024 //
GLOBENEWSWIRE
EU backs Eisai-Biogen Alzheimer`s drug after initial rejection
16 Nov 2024 //
REUTERS
EU regulators endorse meds from BMS, J&J, Eisai and more
15 Nov 2024 //
FIERCE PHARMA
UCB & Biogen’s dapirolizumab pegol paves path for lupus treatment
13 Nov 2024 //
EXPRESSPHARMA
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
13 Nov 2024 //
BIOSPACE
Biogen buys in to molecular glues with deal worth up to $1.45B
30 Oct 2024 //
FIERCE BIOTECH
Biogen raises profit guidance as Leqembi`s launch trudges on
30 Oct 2024 //
FIERCE PHARMA
Eisai Presents Lecanemab Long-Term Data at CTAD Conference
30 Oct 2024 //
GLOBENEWSWIRE
Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer
29 Oct 2024 //
GLOBENEWSWIRE
Biogen and Neomorph Collaborate on Molecular Glue Degraders
29 Oct 2024 //
GLOBENEWSWIRE
CFO Michael McDonnell to Retire in February 2025
28 Oct 2024 //
#N/A
Biogen Reports Positive IGNAZ Phase 2 Results in IgA Nephropathy
26 Oct 2024 //
GLOBENEWSWIRE
Biogen To Present Data At CTAD 2024 Annual Conference
24 Oct 2024 //
GLOBENEWSWIRE
Biogen Announces New Data Presentations At ASN Kidney Week
22 Oct 2024 //
GLOBENEWSWIRE
Suboptimal Leqembi vials could create millions in waste
15 Oct 2024 //
FIERCE PHARMA
Suboptimal Leqembi vials could create millions in waste: study
14 Oct 2024 //
FIERCE PHARMA
Biogen reports promising results for higher dose of Spinraza
10 Oct 2024 //
PRESS RELEASE
Biogen Receives FDA Breakthrough For Felzartamab In AMR In Kidney
09 Oct 2024 //
GLOBENEWSWIRE
New Nusinersen Data Presented At World Muscle Society Congress
08 Oct 2024 //
GLOBENEWSWIRE
Positive Ph3 Results For UCB/Biogen`s Dapirolizumab Pegol
07 Oct 2024 //
PR NEWSWIRE
Biogen And Investors Want US Court To Clarify Class Certification
02 Oct 2024 //
REUTERS
Biogen cans SAGE-324 collaboration after essential tremor fail
27 Sep 2024 //
FIERCE BIOTECH
Sage Therapeutics Ends Biogen Collaboration On SAGE-324
26 Sep 2024 //
BUSINESSWIRE
Biogen-UCB`s lupus drug meets main goal of late-stage trial
24 Sep 2024 //
PRESS RELEASE
Samsung Bioepis and Biogen Receive Positive CHMP
20 Sep 2024 //
GLOBENEWSWIRE
Biogen Board Appoints Two New Independent Directors
12 Sep 2024 //
GLOBENEWSWIRE
Bio-Thera And Biogen Publish TOFIDENCE Phase 3 Trial Data
11 Sep 2024 //
PR NEWSWIRE
C4 Therapeutics Delivers Second Development Candidate To Biogen
10 Sep 2024 //
GLOBENEWSWIRE
Biogen Reports Positive Results For Higher Dose Nusinersen
04 Sep 2024 //
GLOBENEWSWIRE
Biogen to Seek Approval for High-Dose Spinraza After Positive Trial Results
04 Sep 2024 //
FIERCE PHARMA
IGC Pharma Advances IGC-AD1 Toward Trials for Alzheimer`s Anti-Amyloid Treatment
04 Sep 2024 //
BUSINESSWIRE
New Alzheimer`s drug deemed too costly for UK`s state-run health service
22 Aug 2024 //
REUTERS
BioArctic Comments On Lecanemab Approval Rumors In Britain
22 Aug 2024 //
PR NEWSWIRE
Biogen Sued Over Alleged PBM Kickbacks For Tecfidera
21 Aug 2024 //
FIERCE PHARMA
Incyte`s blood cancer drug succeeds late-stage trial
16 Aug 2024 //
REUTERS
Metagenomi axes ALS program after seeing Biogen and Ionis flounder
14 Aug 2024 //
FIERCE BIOTECH
OpenFold AI Consortium Welcomes Six New Members
13 Aug 2024 //
BUSINESSWIRE
Immunic Reports Q2 2024 Results And Provides Corporate Update
08 Aug 2024 //
PR NEWSWIRE
Sangamo secures $50M upfront in neurodegenerative pact with Roche`s Genentech
07 Aug 2024 //
FEIRCE BIOTECH
Sangamo secures $50M upfront in neurodegenerative pact with Roche`s Genentech
06 Aug 2024 //
FIERCE BIOTECH
Biogen Keeps Biosimilars As Leqembi Advances Amid Business Shift
02 Aug 2024 //
FIERCE PHARMA
Biogen Exits Denali Alzheimer`s Collaboration
01 Aug 2024 //
FIERCE BIOTECH
Last year, Biogen’s CEO said no risky deals. Now, he’s ready to be bold
01 Aug 2024 //
FIERCE BIOTECH
Biogen lifts profit forecast, signals progress in turnaround effort
01 Aug 2024 //
REUTERS
Eisai, Biogen Show Leqembi`s Added Benefits Over Time
31 Jul 2024 //
FIERCE PHARMA
Benefit of Eisai and Biogen`s Alzheimer`s drug increases over time, studies suggest
31 Jul 2024 //
REUTERS
Biogen, Beckman Coulter, Fujirebio Collaborate On Alzheimer`s Biomarkers
30 Jul 2024 //
GLOBENEWSWIRE
Alzheimer`s drug from Eisai and Biogen rejected in Europe
27 Jul 2024 //
REUTERS
Update On EU Regulatory Review Of Lecanemab For Early Alzheimer`s
26 Jul 2024 //
GLOBENEWSWIRE
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure
24 Jul 2024 //
PRESS RELEASE
Lilly Aims For Alzheimer`s Market Leadership Following Kisunla Approval
11 Jul 2024 //
FIERCE PHARMA
Biogen Completes Acquisition of HI-Bio
03 Jul 2024 //
CONTRACT PHARMA
Biogen Completes Acquisition of Human Immunology Biosciences
02 Jul 2024 //
GLOBENEWSWIRE
Japan`s Eisai developing dementia drug for US market, Nikkei reports
01 Jul 2024 //
REUTERS
Eisai and Biogen launch Alzheimer`s drug Leqembi in China
28 Jun 2024 //
REUTERS
TOFIDENCE™ (tocilizumab) Biosimilar Approved in the European Union
24 Jun 2024 //
GLOBENEWSWIRE
